Melanie S. Brennan - Concepedia

Author

Melanie S. Brennan

Also Known As

Melanie Brennan, Melanie S. Brennan, Melanie Shackett Brennan

Publications

3.4K

Citations

H-Index

Concepts

All Affiliations

Melanie S. Brennan is an author at Biogen (United States) specializing in medicine, neurodegenerative diseases, and alzheimer's disease.

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	3.1K
2	Biochemistry	2	2	183
3	Immunology	1	1	3K
4	Metabolism	1	1	169
5	Neuroscience	1	1	14

Melanie S. Brennan

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease Jeff Sevigny, Ping Chiao, Thierry Bussière, Nature Neurodegenerative DiseasesAlzheimer's DiseaseMedicineImmunologyDegenerative Pathology	2016	3K
Dimethyl Fumarate and Monoethyl Fumarate Exhibit Differential Effects on KEAP1, NRF2 Activation, and Glutathione Depletion In Vitro Melanie S. Brennan, Maria F. Matos, Bing Li, PLoS ONE Lipid PeroxidationPharmacotherapyDermatologyPsoriatic ArthritisRedox Biology	2015	169
The NRF2 transcriptional target, OSGIN1, contributes to monomethyl fumarate-mediated cytoprotection in human astrocytes Melanie S. Brennan, Maria F. Matos, K. Richter, Scientific Reports	2017	86
Pharmacodynamics of Dimethyl Fumarate Are Tissue Specific and Involve NRF2-Dependent and -Independent Mechanisms Melanie S. Brennan, Hiral Patel, Norm Allaire, Antioxidants and Redox Signaling	2016	57
BIIB042, a novel γ-secretase modulator, reduces amyloidogenic Aβ isoforms in primates and rodents and plaque pathology in a mouse model of Alzheimer's disease Robert H. Scannevin, Sowmya Chollate, Melanie S. Brennan, Neuropharmacology Neurodegenerative DiseasesAlzheimer's DiseaseBiochemistryPlaque PathologyMedicine	2015	14
Different Fumaric Acid Esters Elicit Distinct Pharmacologic Responses Brian T. Wipke, Robert Hoepner, Katrin Straßburger-Krogias, Neurology Neuroimmunology & Neuroinflammation	2021	14

Page 1